From October 13 to 15, 2026, GMED will participate in the 37th A3P International Congress, taking place in Biarritz, France.
On October 15, Madeleine Tom, Lead Conformity Assessment Reviewer, and Julie Dubois, Medical Device Product Assessor & Certification Project Manager, will contribute to the plenary session:
“Article 117 Combination Products: A Notified Bodies’ Perspective”
The presentation will focus on the regulatory pathways applicable to drug-device combination products and on GMED’s experience as a Notified Body in this field.
Topics covered will include:
- Regulatory pathways for combination products
- Article 117 requirements
- The role and expectations of Notified Bodies
- Practical considerations for manufacturers
Click here for details about GMED at A3P Biarritz International Congress:
share
Events
Find an answer to the challenges you are facing in one of our upcoming events: trainings, webinars, forums...